BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26215749)

  • 1. True targeting-derived prostate biopsy: HistoScanning™ remained inadequate despite advanced technical efforts.
    Schiffmann J; Mehring G; Tennstedt P; Manka L; Boehm K; Leyh-Bannurah SR; Karakiewicz PI; Hammerer P; Graefen M; Salomon G
    World J Urol; 2016 Apr; 34(4):495-500. PubMed ID: 26215749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversial evidence for the use of HistoScanning™ in the detection of prostate cancer.
    Schiffmann J; Manka L; Boehm K; Leyh-Bannurah SR; Karakiewicz PI; Graefen M; Hammerer P; Salomon G
    World J Urol; 2015 Dec; 33(12):1993-9. PubMed ID: 25860379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does HistoScanning™ predict positive results in prostate biopsy? A retrospective analysis of 1,188 sextants of the prostate.
    Schiffmann J; Tennstedt P; Fischer J; Tian Z; Beyer B; Boehm K; Sun M; Gandaglia G; Michl U; Graefen M; Salomon G
    World J Urol; 2014 Aug; 32(4):925-30. PubMed ID: 24871425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does prostate HistoScanning™ play a role in detecting prostate cancer in routine clinical practice? Results from three independent studies.
    Javed S; Chadwick E; Edwards AA; Beveridge S; Laing R; Bott S; Eden C; Langley S
    BJU Int; 2014 Oct; 114(4):541-8. PubMed ID: 24224648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
    Gallina A; Maccagnano C; Suardi N; Capitanio U; Abdollah F; Raber M; Salonia A; Scattoni V; Rigatti P; Montorsi F; Briganti A
    BJU Int; 2012 Jul; 110(2 Pt 2):E64-8. PubMed ID: 22093108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of Histoscanning™ prior to prostate biopsy for the diagnosis of prostate adenocarcinoma.
    Núñez-Mora C; García-Mediero JM; Patiño P; Orellana C; Garrido A; Rojo A; Rendón D
    Actas Urol Esp; 2013 Jun; 37(6):342-6. PubMed ID: 23507291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer polar localization on core biopsy predicts pathologic stage.
    Hensley PJ; Bailey LR; Purdom MS; Davenport DL; Strup SE
    Can J Urol; 2016 Dec; 23(6):8551-8556. PubMed ID: 27995850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of ultrasound imaging biomarkers (HistoScanning™) improves staging reliability of prostate biopsies.
    Hamann MF; Meyer D; Knüpfer S; Fuchs J; Jünemann KP; Naumann CM
    BMC Res Notes; 2017 Nov; 10(1):579. PubMed ID: 29121982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sextant-Specific Analysis of Detection and Tumor Volume by HistoScanning™.
    Porres D; Kuru TH; Epplen R; Eck A; Zugor V; Kennes LN; Afram S; Braunschweig T; Knüchel-Clarke R; Pfister D; Heidenreich A
    Urol Int; 2016; 96(2):194-201. PubMed ID: 26555799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low accuracy of routine ultrasound-guided systematic 12-core biopsies in prostate tumor mapping.
    Belas O; Hupertan V; Comperat E; Renard-Penna R; Mozer P; Bitker MO; Rouprêt M
    Can J Urol; 2012 Aug; 19(4):6366-72. PubMed ID: 22892260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of perineal HistoScanning™ template-guided prostate biopsy].
    Hamann MF; Hamann C; Olzem D; Trettel A; Juenemann KP; Naumann CM
    Urologe A; 2015 Nov; 54(11):1596, 1598-601. PubMed ID: 25794587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of extracapsular extension of prostate cancer based on systematic core biopsies.
    Tarján M; Tot T
    Scand J Urol Nephrol; 2006; 40(6):459-64. PubMed ID: 17130097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer.
    Graefen M; Ohori M; Karakiewicz PI; Cagiannos I; Hammerer PG; Haese A; Erbersdobler A; Henke RP; Huland H; Wheeler TM; Slawin K; Scardino PT; Kattan MW
    J Urol; 2004 Jan; 171(1):200-3. PubMed ID: 14665876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens.
    Divrik RT; Eroglu A; Sahin A; Zorlu F; Ozen H
    Urol Oncol; 2007; 25(5):376-82. PubMed ID: 17826653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computer-aided transrectal ultrasound: does prostate HistoScanning™ improve detection performance of prostate cancer in repeat biopsies?
    Hamann MF; Hamann C; Trettel A; Jünemann KP; Naumann CM
    BMC Urol; 2015 Jul; 15():76. PubMed ID: 26223353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A solitary positive prostate cancer biopsy does not predict a unilateral lesion in radical prostatectomy specimens.
    Koie T; Mitsuzuka K; Narita S; Yoneyama T; Kawamura S; Kaiho Y; Tsuchiya N; Tochigi T; Habuchi T; Arai Y; Ohyama C
    Scand J Urol; 2015 Apr; 49(2):103-7. PubMed ID: 25165894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive predictive value of high-grade prostatic intraepithelial neoplasia in initial core needle biopsies of prostate adenocarcinoma--a study with complete sampling of hemi-prostates with corresponding negative biopsy findings.
    Delatour NL; Mai KT
    Urology; 2008 Sep; 72(3):623-7. PubMed ID: 18279923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
    Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
    J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anterior prostate biopsy at initial and repeat evaluation: is it useful to detect significant prostate cancer?
    Pepe P; Pennisi M; Fraggetta F
    Int Braz J Urol; 2015; 41(5):844-8. PubMed ID: 26689509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does cumulative prostate cancer length (CCL) in prostate biopsies improve prediction of clinically insignificant cancer at radical prostatectomy in patients eligible for active surveillance?
    Chen DJ; Falzarano SM; McKenney JK; Przybycin CG; Reynolds JP; Roma A; Jones JS; Stephenson A; Klein E; Magi-Galluzzi C
    BJU Int; 2015 Aug; 116(2):220-9. PubMed ID: 25060664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.